175 related articles for article (PubMed ID: 9380403)
1. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer.
Benz CC; O'Hagan RC; Richter B; Scott GK; Chang CH; Xiong X; Chew K; Ljung BM; Edgerton S; Thor A; Hassell JA
Oncogene; 1997 Sep; 15(13):1513-25. PubMed ID: 9380403
[TBL] [Abstract][Full Text] [Related]
2. The PEA3 Ets transcription factor is a downstream target of the HER2/Neu receptor tyrosine kinase.
O'Hagan RC; Hassell JA
Oncogene; 1998 Jan; 16(3):301-10. PubMed ID: 9467955
[TBL] [Abstract][Full Text] [Related]
3. PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.
Matsui K; Sugimori K; Motomura H; Ejiri N; Tsukada K; Kitajima I
Oncol Rep; 2006 Jul; 16(1):153-8. PubMed ID: 16786139
[TBL] [Abstract][Full Text] [Related]
4. A genomic explanation connecting "Mediterranean diet", olive oil and cancer: oleic acid, the main monounsaturated fatty acid of olive oil, induces formation of inhibitory "PEA3 transcription factor-PEA3 DNA binding site" complexes at the Her-2/neu (erbB-2) oncogene promoter in breast, ovarian and stomach cancer cells.
Menendez JA; Papadimitropoulou A; Vellon L; Lupu R
Eur J Cancer; 2006 Oct; 42(15):2425-32. PubMed ID: 16406575
[TBL] [Abstract][Full Text] [Related]
5. A positive role for PEA3 in HER2-mediated breast tumour progression.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Young LS
Br J Cancer; 2006 Nov; 95(10):1404-9. PubMed ID: 17060941
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
7. Expression of PEA3 and lack of correlation between PEA3 and HER-2/neu expression in breast cancer.
Xia WY; Lien HC; Wang SC; Pan Y; Sahin A; Kuo YH; Chang KJ; Zhou X; Wang H; Yu Z; Hortobagyi G; Shi DR; Hung MC
Breast Cancer Res Treat; 2006 Aug; 98(3):295-301. PubMed ID: 16752078
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of an Ets protein, PEA3, in breast cancer cell lines MDA-MB-361DYT2 and BT474M1.
Yu Z; Xia W; Wang HY; Wang SC; Pan Y; Kwong KY; Hortobagyi GN; Hung MC
Mol Carcinog; 2006 Sep; 45(9):667-75. PubMed ID: 16652376
[TBL] [Abstract][Full Text] [Related]
9. Human manganese superoxide dismutase suppresses HER2/neu-mediated breast cancer malignancy.
Chuang TC; Liu JY; Lin CT; Tang YT; Yeh MH; Chang SC; Li JW; Kao MC
FEBS Lett; 2007 Sep; 581(23):4443-9. PubMed ID: 17719580
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
Hsu MC; Chang HC; Hung WC
Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors.
Lynch CC; Crawford HC; Matrisian LM; McDonnell S
Int J Oncol; 2004 Jun; 24(6):1565-72. PubMed ID: 15138601
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene.
Gum R; Wang SW; Lengyel E; Yu D; Hung MC; Juarez J; Boyd D
Anticancer Res; 1995; 15(4):1167-72. PubMed ID: 7653995
[TBL] [Abstract][Full Text] [Related]
13. The pea3 subfamily ets genes are required for HER2/Neu-mediated mammary oncogenesis.
Shepherd TG; Kockeritz L; Szrajber MR; Muller WJ; Hassell JA
Curr Biol; 2001 Nov; 11(22):1739-48. PubMed ID: 11719215
[TBL] [Abstract][Full Text] [Related]
14. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
15. ESX: a structurally unique Ets overexpressed early during human breast tumorigenesis.
Chang CH; Scott GK; Kuo WL; Xiong X; Suzdaltseva Y; Park JW; Sayre P; Erny K; Collins C; Gray JW; Benz CC
Oncogene; 1997 Apr; 14(13):1617-22. PubMed ID: 9129154
[TBL] [Abstract][Full Text] [Related]
16. A new cis element is involved in the HER2 gene overexpression in human breast cancer cells.
Grooteclaes M; Vernimmen D; Plaza S; Pasleau F; Hodzic D; Winkler-Gol R
Cancer Res; 1999 Jun; 59(11):2527-31. PubMed ID: 10363966
[TBL] [Abstract][Full Text] [Related]
17. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.
Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R
Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435
[TBL] [Abstract][Full Text] [Related]
18. Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.
Bièche I; Tozlu S; Girault I; Onody P; Driouch K; Vidaud M; Lidereau R
Carcinogenesis; 2004 Mar; 25(3):405-11. PubMed ID: 14633660
[TBL] [Abstract][Full Text] [Related]
19. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
20. The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis.
Xing X; Wang SC; Xia W; Zou Y; Shao R; Kwong KY; Yu Z; Zhang S; Miller S; Huang L; Hung MC
Nat Med; 2000 Feb; 6(2):189-95. PubMed ID: 10655108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
